Optimization of pharmacokinetic properties by modification of a carbazole-based cannabinoid receptor subtype 2 (CB2) ligand-Reference-Cited by-同舟云学术

Optimization of pharmacokinetic properties by modification of a carbazole-based cannabinoid receptor subtype 2 (CB2) ligand

Published:2018-01 Issue: Volume:143 Page:1436-1447
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Heimann Dominik,Börgel Frederik,de Vries Henk,Bachmann Kim^ORCID,Rose Victoria E.^ORCID,Frehland Bastian,Schepmann Dirk,Heitman Laura H.,Wünsch Bernhard

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference26 articles.

1. The religious and medicinal uses of Cannabis in China, India and Tibet;Touw;J. Psychoact. Drugs,1981

2. History of cannabis as a medicine: a review;Zuardi;Rev. Bras. Psiquiatr.,2006

3. Structure of a cannabinoid receptor and functional expression of the cloned cDNA;Matsuda;Nature,1990

4. Molecular characterization of a peripheral receptor for cannabinoids;Munro;Nature,1993

5. The CB2 receptor and its role as a regulator of inflammation;Turcotte;Cell. Mol. Life Sci.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dualism of 1,2,4-oxadiazole ring in noncovalent interactions with carboxylic group;Journal of Molecular Structure;2022-08

2. Rational drug design of CB2 receptor ligands: from 2012 to 2021;RSC Advances;2022

3. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI;Molecular Imaging and Biology;2021-10-12

4. In vivo imaging of cannabinoid type 2 receptors, functional and structural alterations in mouse model of cerebral ischemia by PET and MRI;2021-05-10

5. Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor;Bioorganic & Medicinal Chemistry;2021-03